CD44 and ovarian carcinoma: And c-kit, along with Oct4, Nanog, SOX2, CD133, CD44, and ALDH1, has been considered as a cancer stem cell marker in primary non-small cell lung cancer (NSCLC), ovarian cancer and hepatocellular carcinoma [42].